Comments to "Interaction Between Caffeine and Clozapine"
- 1 October 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 15 (5) , 376-377
- https://doi.org/10.1097/00004714-199510000-00015
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.British Journal of Clinical Pharmacology, 1994
- Assessment of Liver Metabolic FunctionClinical Pharmacokinetics, 1994
- Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of ClozapineTherapeutic Drug Monitoring, 1994
- Interaction Between Caffeine and ClozapineJournal of Clinical Psychopharmacology, 1994
- Caffeine metabolism in a healthy Spanish population: N-Acetylator phenotype and oxidation pathwaysClinical Pharmacology & Therapeutics, 1994
- Disposition of clozapine in man: lack of association with debrisoquine and S‐mephenytoin hydroxylation polymorphisms.British Journal of Clinical Pharmacology, 1994
- The use of caffeine for enzyme assays: A critical appraisalClinical Pharmacology & Therapeutics, 1993
- Genetically variable metabolism of antidepressants and neuroleptic drugs in manPharmacogenetics, 1993
- Clinical Pharmacology of CaffeineAnnual Review of Medicine, 1990
- Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.Proceedings of the National Academy of Sciences, 1989